VitroLabs Inc
VitroLabs Inc is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at VitroLabs Inc.
VitroLabs Inc is a company.
Key people at VitroLabs Inc.
Key people at VitroLabs Inc.
VitroLabs Inc. is a biotechnology company founded in 2016 that develops a scalable tissue engineering platform to produce lab-grown leather from animal cells, offering a sustainable alternative to traditional leather. The company creates cell-cultivated leather by taking a one-time collection of cells from animals, which grow in a nutrient-rich environment into durable, luxurious material matching the look, feel, and performance of conventional hides, without ongoing animal sourcing.[1][2][3] This addresses environmental sustainability and animal welfare issues in leather production. VitroLabs serves the fashion and interiors industries, targeting luxury brands like those partnered with Kering, and has raised funding including a Series A led by Agronomics with investors such as Khosla Ventures and Leonardo DiCaprio, plus seed funding from Firstminute Capital.[2][4] Growth momentum includes 10 patents in areas like transcription factors and human proteins, and alignment with the projected $8.15 million cell-cultured leather market by 2030.[2]
VitroLabs emerged from the insight of a scientist and a surgeon who recognized that technology for creating artificial skin for burn victims could be adapted to produce leather.[4] Co-founder and CEO Ingvar Helgason, with a background in the fashion industry, led the effort; the company was incubated at Fashion Tech Lab and received seed funding in 2017 from Firstminute Capital and Fashion Tech Lab.[4] Founded in 2016, it started in Milpitas or San Francisco, California (with later headquarters at 2885 Zanker Road, San Jose), focusing initially on sustainable leather from cow, ostrich, and crocodile cells using stem cell technologies and 3D tissue engineering.[1][2][3][4] Early traction came from proprietary advances in scaling tissue engineering, partnerships like Kering for product testing, and a latest angel funding round.[2]
VitroLabs rides the wave of cellular agriculture and cultivated materials, capitalizing on rising demand for animal-free alternatives amid climate concerns and ethical fashion trends.[1][2] Timing is ideal with the cell-cultured leather market forecasted to hit $8.15 million by 2030, driven by luxury brands seeking sustainable supply chains and regulatory shifts favoring biotech innovations.[2] Market forces like consumer pressure on fast fashion's environmental footprint (e.g., water use, emissions from hides) and investments from agronomics funds amplify this.[2][4] The company influences the ecosystem by pioneering 3D tissue engineering for fashion—starting with leather and pelts, potentially extending to organs—bridging biotech with consumer goods and inspiring similar ventures in biofabrics.[4][5]
VitroLabs is poised to disrupt luxury leather with scalable, ethical production, leveraging patents and partnerships to commercialize amid market growth. Next steps likely include pilot scaling with Kering, expanding to biofur and exotic materials like ostrich, and pursuing further funding beyond its angel round. Trends like precision fermentation synergies and global sustainability mandates will accelerate adoption, potentially evolving VitroLabs into a platform for broader tissue applications, from apparel to medical. This positions it as a leader in biotech's shift toward circular economies, fulfilling its mission to redefine material origins without compromise.[1][2][4]
